Winton Group LTD Aytu Biopharma, Inc Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.35 - $2.95 $77,560 - $169,483	-57,452 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$2.78 - $5.12 $619 - $1,141	223 Added 0.39%	57,452 $165,000
Q2 2021 Aug 10, 2021	BUY	$4.73 - $7.56 $50,043 - $79,984	10,580 Added 22.68%	57,229 $287,000
Q1 2021 Jul 21, 2021	BUY	$6.23 - $9.88 $112,115 - $177,800	17,996 Added 62.81%	46,649 $355,000
Q4 2020 Feb 12, 2021	BUY	$5.98 - $13.5 $171,344 - $386,815	28,653 New	28,653 $171,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.